(ANSA) - Latina, February 17 - Italy will get a
new-generation hepatitis C drug by the end of the week, sources
at the Italian unit of US manufacturer Janssen said in this city
south of Rome Tuesday.
The production of Simeprevir will be boosted by a new
tranche of investments totalling 80 million euros from 2016 to
2021, the sources at the multinational said.
Italy to get new hepatitis C drug
Simeprevir to be made by Janssen at Latina